| Literature DB >> 16603352 |
Christopher M McBride1, Paul A Renhowe, Carla Heise, Johanna M Jansen, Gena Lapointe, Sylvia Ma, Ramon Piñeda, Jayesh Vora, Marion Wiesmann, Cynthia M Shafer.
Abstract
3-Benzimidazol-2-yl-1H-indazole analogs were developed as inhibitors of receptor tyrosine kinases (RTK). The synthesis and SAR of this series is reported.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16603352 DOI： 10.1016/j.bmcl.2006.03.069
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823